A study illuminates the alcohol consumption habits of cancer survivors.
by Jen Tota McGivney
Medical oncologist and lung cancer expert Roy S. Herbst discusses early data on drugs that target a mutated form of the KRAS protein.
by Anna Azvolinsky
Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges.
by Melvin Mann
Letting children know they might have a mutation that increases their risk for cancer can be a challenge for patients. Experts stress there is no right or wrong way to share the information.
by Marci A. Landsmann
FROM THE EDITOR-IN-CHIEF
Increased vaccination rates can help reduce cervical cancer as a worldwide health threat.
by William G. Nelson, MD, PhD
Researchers are working to expand the benefits of immunotherapy by making “cold” tumors “hot” so they can respond better to treatments.
by Kendall K. Morgan
Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.
by Sue Rochman
FORWARD LOOK
New study explores impact of lowering dose due to side effects.
by Jane Langille
Programs aim to increase awareness of benefits.
New law mandates that cancer drugs get tested in kids in clinical trials.
by Sharon Tregaskis
A father with metastatic kidney cancer embraces moments with his 3-year-old son while pondering how he’ll be remembered.
by Adam P. Stern
The number of cancer patients and survivors visiting emergency departments for opioid overdoses more than doubled between 2006 and 2015, but overdoses are still uncommon in this group.
by Emma Yasinski
A study shows that some cancer patients wish they had known more about possible adverse effects of treatment.
by Jon Kelvey
Cervical cancer now accounts for less than 1% of cancer-related deaths among women in the United States.
The first new anti-cancer therapeutics approved in 2020 are for the treatment of two different types of soft tissue sarcoma.
Imaging a patient’s cancer—and the responses generated by the immune system—can provide information that may guide treatment decisions.
Handle With Care
donate to the AACR